Sectors

Sector report: energy Q1 2022

Global Energy Council Q2 2022 editorial by James Mawson, editor in chief, Global Corporate Venturing

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Massachusetts Mutual Life's venture capital arm has formed a fourth fund, which will concentrate on European and Asia-Pacific investments.

CVS Health joined returning backers that could include SoftBank Vision Fund 2, MassMutual Ventures, Jianke and Aviva in a round valuing the digital care service at $1.3bn.

Migdal and Menora Mivtachim helped supply the renewable energy infrastructure developer with fresh funding which will help expand its operations in the UK and Finland.

ServiceNow, Capital One Ventures, Citi Ventures, Splunk Ventures and GV all contributed to the software deployment technology provider's latest round, valuing it at $3.7bn.

Sophie Dingreville, formerly of Munich Re Ventures, has been appointed chief investment officer of BP's digital technology accelerator.

Yangtze River Pharmaceutical Group led Binhui Biopharm's $47m series B-plus round while Sigfox has been snapped up by UnaBiz for under $30m after raising over $300m.

The Sinopharm-backed laboratory animal model developer floated on Shanghai Stock Exchange’s Star Market two years after its last equity funding.

BMW i Ventures and Telekom Innovation Pool both invested in a series A round for the IoT system provider, which had developed dedicated technology products with their parent companies.